These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

681 related items for PubMed ID: 23403805

  • 1. Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation.
    Wu X, Hayes D, Zwischenberger JB, Kuhn RJ, Mansour HM.
    Drug Des Devel Ther; 2013; 7():59-72. PubMed ID: 23403805
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.
    Meenach SA, Anderson KW, Zach Hilt J, McGarry RC, Mansour HM.
    Eur J Pharm Sci; 2013 Jul 16; 49(4):699-711. PubMed ID: 23707466
    [Abstract] [Full Text] [Related]

  • 7. Advanced spray dried proliposomes of amphotericin B lung surfactant-mimic phospholipid microparticles/nanoparticles as dry powder inhalers for targeted pulmonary drug delivery.
    Gomez AI, Acosta MF, Muralidharan P, Yuan JX, Black SM, Hayes D, Mansour HM.
    Pulm Pharmacol Ther; 2020 Oct 16; 64():101975. PubMed ID: 33137515
    [Abstract] [Full Text] [Related]

  • 8. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
    Li X, Vogt FG, Hayes D, Mansour HM.
    J Aerosol Med Pulm Drug Deliv; 2014 Apr 16; 27(2):81-93. PubMed ID: 24502451
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy.
    Acosta MF, Muralidharan P, Grijalva CL, Abrahamson MD, Hayes D, Fineman JR, Black SM, Mansour HM.
    Ther Adv Respir Dis; 2021 Apr 16; 15():1753466621998245. PubMed ID: 33719747
    [No Abstract] [Full Text] [Related]

  • 13. Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate.
    Simon A, Amaro MI, Cabral LM, Healy AM, de Sousa VP.
    Int J Pharm; 2016 Mar 30; 501(1-2):124-38. PubMed ID: 26836711
    [Abstract] [Full Text] [Related]

  • 14. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
    Li X, Vogt FG, Hayes D, Mansour HM.
    J Pharm Sci; 2014 Sep 30; 103(9):2937-2949. PubMed ID: 24740732
    [Abstract] [Full Text] [Related]

  • 15. Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers.
    Acosta MF, Abrahamson MD, Encinas-Basurto D, Fineman JR, Black SM, Mansour HM.
    AAPS J; 2020 Nov 16; 23(1):2. PubMed ID: 33200330
    [Abstract] [Full Text] [Related]

  • 16. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
    Lu W, Rades T, Rantanen J, Yang M.
    Int J Pharm; 2019 Jun 30; 565():1-8. PubMed ID: 30999050
    [Abstract] [Full Text] [Related]

  • 17. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L, Sun S, Parumasivam T, Denman JA, Gengenbach T, Tang P, Mao S, Chan HK.
    Eur J Pharm Biopharm; 2016 May 30; 102():132-41. PubMed ID: 26970252
    [Abstract] [Full Text] [Related]

  • 18. Development of a Carrier Free Dry Powder Inhalation Formulation of Ketotifen for Pulmonary Drug Delivery.
    Azari F, Ghanbarzadeh S, Safdari R, Yaqoubi S, Adibkia K, Hamishehkar H.
    Drug Res (Stuttg); 2020 Jan 30; 70(1):26-32. PubMed ID: 31533157
    [Abstract] [Full Text] [Related]

  • 19. Co-spray dried carbohydrate microparticles: crystallisation delay/inhibition and improved aerosolization characteristics through the incorporation of hydroxypropyl-β-cyclodextrin with amorphous raffinose or trehalose.
    Amaro MI, Tajber L, Corrigan OI, Healy AM.
    Pharm Res; 2015 Jan 30; 32(1):180-95. PubMed ID: 25074469
    [Abstract] [Full Text] [Related]

  • 20. Assessment of Dry Powder Inhaler Carrier Targeted Design: A Comparative Case Study of Diverse Anomeric Compositions and Physical Properties of Lactose.
    Pinto JT, Zellnitz S, Guidi T, Roblegg E, Paudel A.
    Mol Pharm; 2018 Jul 02; 15(7):2827-2839. PubMed ID: 29856921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.